Gerresheimer AG Receives Shareholder Support for Strategic Moves

Gerresheimer AG's recent Annual General Meeting witnessed a majority vote in favor of all proposed resolutions, indicating strong shareholder backing. Key decisions included the election of four new shareholder representatives to the Supervisory Board, with Markus Sieger assuming the role of Chairman. The company aims to reduce debt and engage in comprehensive refinancing strategies to enhance its financial health.

Notably, the discharge of the Supervisory Board and former Executive Board members was deferred due to ongoing investigations. Gerresheimer has addressed past accounting errors in its 2025 financial statements. The company also plans to focus more on high-quality drug delivery devices and medical packaging.

With 41.59% participation of share capital, all agenda items were approved. KPMG AG was appointed as the independent auditor for 2026. The meeting signifies a clear direction towards financial stability and growth for Gerresheimer AG.